DCX Regulatory Sequence for Neuronal Cell Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and isolating neuronal restricted precursor cells in the adult mammalian CNS are limited by the lack of specific markers and gene regulation sequences, leading to difficulties in identifying and quantifying neurogenesis, particularly due to the non-specificity of existing markers and the limitations of methods like BrdU incorporation and retroviral labeling.
Innovation Solution
The use of regulatory sequences, specifically the doublecortin (DCX) regulatory sequence, which drives early transient expression in proliferative neuronal determined cells, allowing for specific and quantifiable indicators of neurogenesis by promoting the expression of heterologous nucleotide sequences in neuronal restricted cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing markers (nestin, Notch1, Musashi, PSA-NCAM, βIII tubulin) are used to detect neuronal restricted precursor cells, then cell detection is possible, but the markers lack specificity and are expressed in multiple cell types including non-neuronal cells
Solution Approach 1:
The patent extracts and utilizes the endogenous doublecortin (DCX) protein itself as the marker, rather than relying on external or indirect markers. DCX is naturally expressed specifically in neuronal restricted precursor cells during neurogenesis, providing inherent specificity without the cross-reactivity problems of previous markers. This extraction of the naturally occurring specific marker resolves the contradiction between detection capability and specificity.
Solution Approach 2:
The invention employs cell-type-specific promoters (such as the DCX promoter) to drive reporter gene expression locally and specifically in neuronal restricted precursor cells. This ensures that the marker is expressed only in the desired cell population with high spatial and cellular specificity, eliminating the non-specific expression seen with previous markers across multiple cell types.
2Productivity
If BrdU incorporation or retroviral labeling methods are used to identify neurogenesis, then cell proliferation can be detected, but these methods have limitations in specificity and quantification
Solution Approach 1:
The patent uses reporter genes (such as GFP, luciferase, or beta-galactosidase) as intermediaries that are under the control of cell-type-specific promoters. These reporters provide a measurable signal that specifically marks neuronal restricted precursor cells, enabling both efficient detection and accurate quantification of neurogenesis without the limitations of BrdU incorporation or retroviral labeling methods.
Solution Approach 2:
The invention replaces the mechanical/chemical methods of BrdU incorporation and retroviral labeling with a genetic regulation system using cell-type-specific promoters driving reporter gene expression. This substitution provides a more specific, quantifiable, and less invasive method for detecting and measuring neurogenesis in both in vitro and in vivo systems.
3Ease of manufacture
If non-specific markers are used for cell isolation, then cell separation can be performed, but the isolation lacks purity and specificity for neuronal restricted precursor cells
Solution Approach 1:
The patent employs cell-type-specific promoters to drive reporter gene expression exclusively in neuronal restricted precursor cells. This localized and specific expression pattern enables highly pure isolation of the target cell population through reporter-based selection methods, achieving both ease of isolation and high purity simultaneously by targeting the unique genetic signature of these cells.
Solution Approach 2:
The invention extracts and utilizes the endogenous DCX gene expression pattern as a unique identifier for neuronal restricted precursor cells. By harnessing this naturally occurring specific expression pattern, the method achieves high-purity isolation without requiring complex multi-marker systems or risking contamination from non-specific markers.
Data Source
AI summary
The present invention relates to the use of regulatory sequences for mediating specific, early transient expression in proliferative neuronal determined cells. Furthermore, the uses of recombinant nucleic acid molecules comprising said defined regulatory sequences for mediating specific, early transient expression in proliferative neuronal determined cells as well as for the generation of non-human transgenic organisms and/or host cells are disclosed. In addition, the invention provides for transgenic non-human animals and/or host cells comprising said regulatory sequences and/or recombinant nucleic acid molecules. The invention also describes methods for the preparation of such vectors, host cells and transgenic non-human animals as well as methods for the detection and/or isolation of neuronal determined cells. Additionally, methods for screening of compounds capable of regulating neuronal determined cell activity, neurogenesis, stimulating proliferation of neuronally committed precursor cells and/or neuronal differentiation are provided and the invention also relates to methods for the detection and analysis of neuronal differentiation, neuronal migration and/or neuronal determination processes. Finally, the invention relates to diagnostic and pharmaceutical compositions comprising the regulatory sequences, recombinant nucleic acid molecules, host-cells or isolated neuronal determined cells described herein.